Description
This oral capsule supplies TB-500, a fragment of the actin-binding protein thymosin beta-4, in a solid-dose research preparation.
Laboratory studies in cell and animal models have explored angiogenesis, cellular motility, matrix turnover, and inflammatory signaling. The oral capsule format supports delivery-route research and simplified handling.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.
Reviews
There are no reviews yet.